MelaNostrum: a consensus questionnaire of standardized epidemiologic and clinical variables for melanoma risk assessment by the melanostrum consortium

Background Many melanoma observational studies have been carried out across different countries and geographic areas using heterogeneous assessments of epidemiologic risk factors and clinical variables. Aim To develop a consensus questionnaire to standardize epidemiologic and clinical data collectio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the European Academy of Dermatology and Venereology 2018-12, Vol.32 (12), p.2134-2141
Hauptverfasser: Stratigos, Alexander J., Fargnoli, Maria Concetta, De Nicolo, Arcangela, Peris, Ketty, Puig, Susana, Soura, Efthymia, Menin, Chiara, Calista, Donato, Ghiorzo, Paola, Mandala, Mario, Massi, Daniela, Rodolfo, Monica, Del Regno, Laura, Stefanaki, Irene, Gogas, Helen, Bataille, Veronique, Tucker, Margaret A., Whiteman, David, Nagore, Eduardo, Landi, Maria Teresa
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Many melanoma observational studies have been carried out across different countries and geographic areas using heterogeneous assessments of epidemiologic risk factors and clinical variables. Aim To develop a consensus questionnaire to standardize epidemiologic and clinical data collection for melanoma risk assessment. Methods We used a stepwise strategy that included: compilation of variables from case–control datasets collected at various centres of the MelaNostrum Consortium; integration of variables from published case–control studies; consensus discussion of the collected items by MelaNostrum members; revision by independent experts; addition of online tools and image‐based charts; questionnaire testing across centres and generation of a final draft. Results We developed a core consensus questionnaire (MelanoQ) that includes four separate sections: A. general and demographic data; B. phenotypic and ultraviolet radiation exposure risk factors and lifestyle habits; C. clinical examination, medical and family history; and D. diagnostic data on melanoma (cases only). Accompanying online tools, informative tables, and image‐based charts aid standardization. Different subsections of the questionnaire are designed for self‐administration, patient interviews performed by a physician or study nurse, and data collection from medical records. Conclusions The MelanoQ questionnaire is a useful tool for the collection and standardization of epidemiologic and clinical data across different studies, centres, cultures and languages. This will expedite ongoing efforts to compile high‐quality data for pooled analyses or meta‐analyses and offer a solid base for the design of clinical, epidemiologic and translational studies on melanoma.
ISSN:0926-9959
1468-3083
DOI:10.1111/jdv.15208